Wikipedia:Articles for deletion/AryoGen


 * The following discussion is an archived debate of the proposed deletion of the article below. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review).  No further edits should be made to this page.

The result was   keep. The Bushranger One ping only 07:33, 5 September 2012 (UTC)

AryoGen

 * – ( View AfD View log  •  Stats )

Appears to be a non-notable company Nouniquenames (talk) 05:38, 29 August 2012 (UTC)
 * Probably keep - agree with nom that it appears to be a non-notable company but a little bit of geographic context is probably relevant here. The following took some work to find but:
 * - a reprinted article originally from the Tehran Times noting that the President of Iran launched their new product.
 * - from the National Library of Australia; record of an article that appeared in the Mena Report.
 * - from the Iranian registry of clinical trials (not a source by any means but worth noting).
 * - although the site seems a bit questionable.
 * Am on the fence about whether this constitutes significant coverage or whether it's reliable. How reliable / independent can sources be if they are in Iran? I just don't know. If anything, it could possibly be Merged in some fashion with the company's two pharma products, AryoSeven and CinnoVex. Or they could be merged with it. All these articles were created and substantially contributed to by the same editor (User:Asemi) and he has been (appropriately) informed by the nominator (nice work). Would be interested to get his take. Stalwart 111  (talk) 06:39, 29 August 2012 (UTC)


 * Deserved to keep and not agree with merge or deletion - As far as I found in articles (mostly in Persian) the company will affect on GDP of the country (health's share) notabely and will be in the middle of List of biotechnology companies reagarding its 2012 revenue. The company has a significance role in the heathcare systems in the region and according to company's plan they will export their medicine to Europe upon approval of their early registrations in European countries. International patients will have benefit of using wikipedia information while they recieve its vital biomedicine. European paitients will welcome these type of safe, effective and viatal biomedicine since Aryogen is making biogeneric drugs and deliver it to patient with affordable price. The company was a very big spin off the CinnaGen (which one of its main product is CinnoVex) and now is multiple time bigger than its mother company.
 * - Another example of company's news in the media (one of many).Asemi (talk) 11:25, 29 August 2012 (UTC)


 * Keep – Meets WP:CORPDEPTH per:
 * IRAN, ISLAMIC REPUBLIC OF : Aryogen produces locally made medicines in Iran; helps Iran save up to $100 mln annually. - Mena Report | HighBeam Research
 * World's 2nd factor VII factory opened in Iran. - Mehr News Agency (MNA) | HighBeam Research
 * — Northamerica1000(talk) 01:42, 30 August 2012 (UTC)
 * Note: This debate has been included in the list of Medicine-related deletion discussions.  • Gene93k (talk) 16:52, 30 August 2012 (UTC)
 * Note: This debate has been included in the list of Business-related deletion discussions.  • Gene93k (talk) 16:53, 30 August 2012 (UTC)
 * The above discussion is preserved as an archive of the debate. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.